American International Group, Inc. Dynavax Technologies Corp Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$11.7 - $14.98 $7,289 - $9,332	-623 Reduced 0.88%	69,873 $867,000
Q4 2023 Feb 13, 2024	SELL	$13.09 - $14.98 $7,422 - $8,493	-567 Reduced 0.8%	70,496 $985,000
Q3 2023 Nov 13, 2023	BUY	$12.64 - $14.99 $25,697 - $30,474	2,033 Added 2.95%	71,063 $1.05 Million
Q2 2023 Aug 04, 2023	BUY	$9.85 - $13.17 $37,695 - $50,401	3,827 Added 5.87%	69,030 $891,000
Q1 2023 May 12, 2023	BUY	$9.44 - $11.88 $2,813 - $3,540	298 Added 0.46%	65,203 $639,000
Q4 2022 Feb 10, 2023	BUY	$10.27 - $13.29 $1,365 - $1,767	133 Added 0.21%	64,905 $690,000
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $7,119 - $12,504	717 Added 1.12%	64,772 $676,000
Q2 2022 Aug 12, 2022	BUY	$7.45 - $12.83 $78,441 - $135,087	10,529 Added 19.67%	64,055 $806,000
Q1 2022 May 13, 2022	SELL	$9.75 - $14.44 $36,738 - $54,409	-3,768 Reduced 6.58%	53,526 $580,000
Q4 2021 Feb 11, 2022	SELL	$13.17 - $20.94 $22,573 - $35,891	-1,714 Reduced 2.9%	57,294 $806,000
Q3 2021 Nov 12, 2021	SELL	$9.16 - $19.83 $12,842 - $27,801	-1,402 Reduced 2.32%	59,008 $1.13 Million
Q2 2021 Aug 13, 2021	SELL	$7.25 - $10.99 $10,998 - $16,671	-1,517 Reduced 2.45%	60,410 $595,000
Q1 2021 May 07, 2021	BUY	$4.57 - $11.18 $749 - $1,833	164 Added 0.27%	61,927 $609,000
Q4 2020 Feb 12, 2021	SELL	$3.73 - $5.6 $6,609 - $9,923	-1,772 Reduced 2.79%	61,763 $275,000
Q3 2020 Nov 04, 2020	BUY	$4.32 - $11.7 $38,175 - $103,392	8,837 Added 16.16%	63,535 $275,000
Q2 2020 Aug 12, 2020	BUY	$2.94 - $9.1 $15,764 - $48,794	5,362 Added 10.87%	54,698 $485,000
Q1 2020 May 04, 2020	SELL	$2.27 - $6.2 $6,469 - $17,670	-2,850 Reduced 5.46%	49,336 $174,000
Q4 2019 Feb 05, 2020	SELL	$3.46 - $6.93 $1,522 - $3,049	-440 Reduced 0.84%	52,186 $299,000
Q3 2019 Nov 08, 2019	BUY	$2.69 - $4.85 $30,725 - $55,396	11,422 Added 27.72%	52,626 $188,000
Q2 2019 Aug 13, 2019	BUY	$3.65 - $7.89 $5,281 - $11,416	1,447 Added 3.64%	41,204 $164,000
Q1 2019 May 06, 2019	SELL	$7.08 - $12.09 $9,126 - $15,584	-1,289 Reduced 3.14%	39,757 $291,000
Q4 2018 Feb 13, 2019	SELL	$8.14 - $13.28 $2,564 - $4,183	-315 Reduced 0.76%	41,046 $376,000
Q3 2018 Nov 09, 2018	BUY	$11.85 - $16.0 $8,816 - $11,904	744 Added 1.83%	41,361 $513,000
Q2 2018 Aug 08, 2018	BUY	$15.15 - $20.75 $25,876 - $35,441	1,708 Added 4.39%	40,617 $619,000
Q1 2018 May 07, 2018	SELL	$14.65 - $19.9 $30,662 - $41,650	-2,093 Reduced 5.1%	38,909 $772,000
Q4 2017 Feb 09, 2018	BUY	$17.3 - $24.08 $10,431 - $14,520	603 Added 1.49%	41,002 $767,000
Q3 2017 Nov 09, 2017	BUY	$15.2 - $21.5 $614,064 - $868,578	40,399	40,399 $869,000

Others Institutions Holding DVAX

# of Institutions

259

Shares Held

132M

Call Options Held

371K

Put Options Held

99.2K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.39B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account